74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Atara Biotherapeutics Inc
Open
SectorHealthcare
11.58 4.04
Overview
Share price change
24h
Min
10.1
Max
11.24
Recommendations | Buy |
|---|---|
12 Months Forecast | +36.86% upside |
Next Earnings | 15 Aug 2025 |
|---|
News Sentiment
By Acuity
3%
97%
1 / 374 Healthcare
Technical Score
By Trading Central
Confidence
Weak Bearish Evidence
Atara Biotherapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Atara Biotherapeutics Inc Forecast
Price Target
By TipRanks
36.86% upside
12 Months Forecast
Average 15 USD 36.86%
High 17 USD
Low 13 USD
Based on 2 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
1 / 374 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
$
